SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (728)12/18/2004 1:22:21 AM
From: tuck  Read Replies (1) of 897
 
I think insurers may disappoint both NBIX and SEPR; you guys got any thoughts on that (an article by Motley Fool's Brian Gorman notes this concern, too)? But that's two or three very wise folks talking me out of shorting NBIX (that would have been for a few bucks, max, a trade, really).

But I'm really most interested in what you & Peter -- and anyone else who wants to chime in -- think of the APPX situation, and perhaps of EYET. I haven't had time to look at the label they got.

And, too, if folks are starting to see rich valuations or high risk/reward (in being long) out there.

I sold my January SEPR options today.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News